H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares.
H. Lundbeck A/S Stock Performance
The stock has a fifty day simple moving average of $22.00 and a two-hundred day simple moving average of $22.00. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.71 and a current ratio of 1.15. The stock has a market cap of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Recommended Stories
- Five stocks we like better than H. Lundbeck A/S
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- What Ray Dalio’s Latest Moves Tell Investors
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.